Clinical features of hepatocellular carcinoma with hepatitis B virus among patients on Nucleos(t) ide analog therapy

by Li Liu
Published 2020-02-01

The rtA181 Mutation Produces Similar Clinical and Cellular Characteristics in Patients infected with Hepatitis B Virus Genotypes B and C

by Li Ping, Xiong Xi, Zhang Xin, Yang Zhi-guo, Gao Lei, Wang Mao-rong
Published 2014-12-01

Factors associated with non-compliance with breastfeeding recommendation: a retrospective survey in hepatitis B virus-infected mothers who had taken Nucleos(t)ide analogs during pr...

by Er-Mei Li, Li-Xin Xiao, Zhen Xu, Zhi-Shuo Mo, Jia-Qian Li, Yong-Yu Mei, Chao-Shuang Lin
Published 2021-08-01

A scoring model predicts hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with nucleos(t)ide analogs: real-world clinical practice

by Mingfan Geng, Yuxin Li, Fangyuan Gao, Le Sun, Xue Yang, Rui Wang, Jialiang Chen, Qun Zhang, Gang Wan, Xianbo Wang
Published 2017-09-01

Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs

by Ming-Chao Tsai, Chien-Hung Chen, Tsung-Hui Hu, Sheng-Nan Lu, Chuan-Mo Lee, Jing-Houng Wang, Chao-Hung Hung
Published 2017-07-01

Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B

by Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Koichi Takaguchi, Makoto Nakamuta, Atsushi Hiraoka, Keizo Kato, Hiroshi Abe, Shigeru Mikami, Noritomo Shimada, Makoto Chuma, Akito Nozaki, Haruki Uojima, Chikara Ogawa, Toru Asano, Joji Tani, Asahiro Morishita, Tomonori Senoh, Naoki Yamashita, Tsunekazu Oikawa, Yoshihiro Matsumoto, Mai Koeda, Yuji Yoshida, Tomohide Tanabe, Tomomi Okubo, Taeang Arai, Korenobu Hayama, Ai‐Nakagawa Iwashita, Chisa Kondo, Toshifumi Tada, Hidenori Toyoda, Takashi Kumada, Katsuhiko Iwakiri
Published 2021-01-01

Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional Study

by Li Y, Chen A, Wang H, Han L, Wang R, Zhang G, Yuan Y
Published 2021-08-01

Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy

by Tien-Ching Lin, Wen-Chun Liu, Yu-Hsiang Hsu, Jia-Jhen Lin, Yen-Cheng Chiu, Hung-Chih Chiu, Pin-Nan Cheng, Chiung-Yu Chen, Ting-Tsung Chang, I-Chin Wu
Published 2019-11-01

Genotypic Resistance Remains A Concern In Chronic Hepatitis B Patients With High Viral Load After Lamivudine And Adefovir Combination Therapy

by Huang M, Zhong J, Lu C, Deng F, Li L, Nong Y, Liang L, Qin H, Deng Y
Published 2019-10-01

The Impact of Nucleos(t)ide Analogs Off-Therapy Among Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis

by Mian Wang, Mingxia Qian, Rongrong Fu, Yiqin Zhang, Xinlan Shen, Dengyuan Yue, Ning Wang, Lei Yang
Published 2021-09-01

Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog

by Ji X, Xia M, Zhou B, Liu S, Liao G, Cai S, Zhang X, Peng J
Published 2020-06-01

Inappropriate cessation of nucleos(t)ide analog associated with reduced liver transplant-free survival in patients with HBV-related acute on chronic liver failure

by Hong Shi, Gemin Xiao, Mei Liao, Lihua Zheng, Yusheng Jie, Guoli Lin, Yutian Chong
Published 2021-02-01

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy

by Honglian Gui, Yan Huang, Gangde Zhao, Lichang Chen, Wei Cai, Hui Wang, Qing Guo, Qing Xie
Published 2021-08-01

Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs

by Tao Li, Feng Liu, Lixin Zhang, Qian Ye, Xiaoping Fan, Yan Xue, Lei Wang
Published 2018-01-01

Predictors of sustained virologic response after discontinuation of nucleos(t)ide analog treatment for chronic hepatitis B

by Jie Peng, Jiawei Cao, Tao Yu, Shaohang Cai, Zhandong Li, Xiaoyong Zhang, Jian Sun
Published 2015-01-01

Circulating miR-122 Is a Predictor for Virological Response in CHB Patients With High Viral Load Treated With Nucleos(t)ide Analogs

by Yin Wu, Chang Gao, Shaohang Cai, Muye Xia, Guichan Liao, Xiaoyong Zhang, Jie Peng
Published 2019-03-01

Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy

by Nai-Hsuan Chien, Yen-Tsung Huang, Chun-Ying Wu, Chi-Yang Chang, Ming-Shiang Wu, Jia-Horng Kao, Lein-Ray Mo, Chi-Ming Tai, Chih-Wen Lin, Tzeng-Huey Yang, Jaw-Town Lin, Yao-Chun Hsu
Published 2017-12-01

Hepatitis B viral factors and treatment responses in chronic hepatitis B

by Chih-Lin Lin, Jia-Horng Kao
Published 2013-06-01

Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy

by Ying Xu, Yu Liu, Miaoxian Zhao, Yunqing Chen, Cantao Xie, Mingxing Gong, Haohui Deng, Xueying Li, Jian Sun, Jinlin Hou, Hongkai Wu, Zhanhui Wang
Published 2017-09-01

Novel Therapies in HBV Infection

by Giuseppe Foti, Vincenzo Scaglione, Carlo Torti
Published 2019-12-01